TY - JOUR
T1 - Analysis of exonic deletions in a large population study provides novel insights into NRXN1 pathology
AU - Montalbano, Simone
AU - Krebs, Morten Dybdahl
AU - Rosengren, Anders
AU - Vaez, Morteza
AU - Hellberg, Kajsa Lotta Georgii
AU - Mortensen, Preben B.
AU - Børglum, Anders D.
AU - Geschwind, Daniel H.
AU - Bækvad-Hansen, Marie
AU - Bybjerg-Grauholm, Jonas
AU - Pedersen, Marianne Giørtz
AU - Petersen, Liselotte V.
AU - Christensen, Jakob
AU - Agerbo, Esben
AU - Pedersen, Carsten B.
AU - Vilhjálmsson, Bjarni J.
AU - Meijsen, Joeri
AU - Appadurai, Vivek
AU - Zetterberg, Richard
AU - Gådin, Jesper
AU - Schork, Andrew J.
AU - Buil, Alfonso
AU - Als, Thomas D.
AU - Grove, Jakob
AU - Mors, Ole
AU - Nordentoft, Merete
AU - Hougaard, David M.
AU - Raznahan, Armin
AU - Thompson, Wesley K.
AU - Helenius, Dorte
AU - Werge, Thomas
AU - Ingason, Andrés
AU - iPSYCH Investigators
PY - 2024/12
Y1 - 2024/12
N2 - The NRXN1 locus is a hotspot for non-recurrent copy number variants and exon-disrupting NRXN1 deletions have been associated with increased risk of neurodevelopmental disorders in case-control studies. However, corresponding population-based estimates of prevalence and disease-associated risk are currently lacking. Also, most studies have not differentiated between deletions affecting exons of different NRXN1 splice variants nor considered intronic deletions. We used the iPSYCH2015 case-cohort sample to obtain unbiased estimates of the prevalence of NRXN1 deletions and their associated risk of autism, schizophrenia, depression, and ADHD. Most exon-disrupting deletions affected exons specific to the alpha isoform, and almost half of the non-exonic deletions represented a previously reported segregating founder deletion. Carriage of exon-disrupting NRXN1 deletions was associated with a threefold and twofold increased risk of autism and ADHD, respectively, whereas no significantly increased risk of depression or schizophrenia was observed. Our results highlight the importance of using population-based samples in genetic association studies.
AB - The NRXN1 locus is a hotspot for non-recurrent copy number variants and exon-disrupting NRXN1 deletions have been associated with increased risk of neurodevelopmental disorders in case-control studies. However, corresponding population-based estimates of prevalence and disease-associated risk are currently lacking. Also, most studies have not differentiated between deletions affecting exons of different NRXN1 splice variants nor considered intronic deletions. We used the iPSYCH2015 case-cohort sample to obtain unbiased estimates of the prevalence of NRXN1 deletions and their associated risk of autism, schizophrenia, depression, and ADHD. Most exon-disrupting deletions affected exons specific to the alpha isoform, and almost half of the non-exonic deletions represented a previously reported segregating founder deletion. Carriage of exon-disrupting NRXN1 deletions was associated with a threefold and twofold increased risk of autism and ADHD, respectively, whereas no significantly increased risk of depression or schizophrenia was observed. Our results highlight the importance of using population-based samples in genetic association studies.
UR - http://www.scopus.com/inward/record.url?scp=85212680913&partnerID=8YFLogxK
U2 - 10.1038/s41525-024-00450-8
DO - 10.1038/s41525-024-00450-8
M3 - Journal article
C2 - 39695155
SN - 2056-7944
VL - 9
JO - npj Genomic Medicine
JF - npj Genomic Medicine
IS - 1
M1 - 67
ER -